Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Oct 19 (Reuters) - Biosynex SA ALBIO.PA :
* RESUMPTION OF GROWTH IN THE 3RD QUARTER 2023: +10%
* OUTLOOK: CONFIRMATION OF 2023 TURNOVER LANDING TOWARDS
€100 M
* Q3 TOTAL GROUP REVENUE EUR 24.4 MILLION VERSUS EUR 22.1
MILLION
YEAR AGO
* ACTIVITY EXCLUDING COVID-19 STOOD AT EUR 60.4 MILLION AT
THE END
OF SEPTEMBER, AN INCREASE OF 63%
Source text for Eikon: ID:nEQr3p33a
Further company coverage: ALBIO.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biosynex SA
See all newsBrief: Biosynex FY Revenue Down To EUR 93.1 Million
Brief: Biosynex Announces Completion Of Merger-Absorption Of Theradiag
Brief: Biosynex Q3 Group Revenue Rises To EUR 24.4 Mln
Brief: Biosynex Announces Its Subsidiary Procisedx Acquires Two U.S. Patents
Brief: Biosynex's Procisedx Obtains First FDA Approvals